Risk Factors Identified for All-Cause Mortality in Cancer Patients With COVID-19
Researchers assessed the risk for all-cause mortality in cancer patients with COVID-19.
COVID19
Many Young Cancer Survivors Report COVID-19 Vaccine Hesitancy
37.1 percent of adolescent and young adult cancer survivors report vaccine hesitancy; higher odds of hesitancy for females.
Convalescent Plasma Use Inversely Linked to COVID-19 Mortality
Reduction in CCP use may have resulted in 29,000 excess deaths in the U.S. from mid-November 2020 to February 2021.
Some Prisons Highly Successful in Vaccinating Inmates
Success in prisons could convince some in the general public to get vaccinated.
Response to COVID-19 Vaccine Variable in Multiple Myeloma Patients
Considerable variation seen in magnitude of antibody response, from 5 to 7,882 AU/mL, following two doses of mRNA COVID-19 vaccine.
Vaccine Expert Discusses EUA of COVID-19 Vaccine for Adolescents
The expanded EUA of the COVID-19 vaccine “will be the biggest positive change for adolescents since the beginning of the lockdown in March 2020.”
— Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP
SARS-CoV-2 Reinfection Risk Low Among Health Care Workers
Risk for reinfection was significantly reduced by 85 percent with the presence of antibodies.
Convalescent Plasma May Cut Deaths in Hematologic Cancer and COVID-19
Lower 30-day mortality seen in hospitalized adults, including those admitted to ICU, requiring mechanical ventilation.
Moderna COVID-19 Vaccine Highly Effective in Children 12 and Older
Side effects among adolescents who received the Moderna vaccine were similar to those reported in adults.
Poll Finds Herd Immunity in U.S. Possible by Summer
In latest KFF survey, 62 percent of respondents said they had received at least one dose of a COVID-19 vaccine.
- Loading...
Loading...
Next post in General Hematology
Loading... 
Loading...